Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
批准号:
8015867
负责人:
NELSON RUIZ-OPAZO
金额:
$40.63万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-20 至 2014-06-30
关键词:
AddressAgeAnimal ModelArteriesBlood PressureCardiovascular DiseasesCardiovascular systemCarotid ArteriesChronic Kidney FailureClinical ResearchCollagenCoronary heart diseaseDataDevelopmentDiseaseElastinEnvironmentEpigenetic ProcessEssential HypertensionEtiologyFemaleGene ExpressionGenesGeneticGenetic Predisposition to DiseaseGoalsHousingHypertensionImplantInbred Dahl RatsInterventionInvestigationLeadLifeMeasurementMeasuresModelingMolecularMolecular GeneticsMonitorOrganOutcomePathway interactionsPhysiologic pulsePlayPredispositionPrevention strategyQuantitative Trait LociRattusResearchResearch ProposalsResistanceResolutionRiskRoleStressStrokeStructureSusceptibility GeneSystemTestingTimeTransgenic OrganismsUltrasonographyWorkarterial stiffnessexperiencegene environment interactiongenetic linkage analysisgenetic variantgenome wide association studygenome-wide linkageinsightmalemeetingsminiaturizenanonew technologypublic health relevancesalt sensitivesexsystems researchtrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our long term goal is to elucidate the etiology of essential or polygenic hypertension with a focus on the elucidation of genetic variants that underlie hypertension susceptibility and gene-environment interactions which exacerbate hypertension susceptibility and end-organ disease. The emerging importance of arterial stiffening measured as pulse wave velocity or PWV in clinical studies demonstrating the association of increased PWV and cardiovascular outcomes (stroke, coronary heart disease, and chronic kidney disease) has pinpointed a likely robust predictive parameter, but at the same time highlighted the need for animal model studies to address mechanisms. Accordingly, this research proposal focuses on RFA-stated goals: #1) "to explore the temporal relationship between arterial stiffening and the development of hypertension in an animal model", and #2) to conduct "cellular and molecular investigation of mechanisms that lead to conduit artery stiffening in the context of (essential/polygenic) hypertension". To accomplish this we have prioritized the following specific aims: Aim 1. Examine the temporal relation between large artery stiffening (measured as aortic PWV and strain, carotid PWV and strain via high-resolution ultrasonography), and the development of salt-sensitive hypertension (measured via non-stress 24/7 telemetric BP analysis of SBP, DBP, MAP and PP) and stroke in both male and female stroke-prone Dahl S rats. Aim 2. Define the temporal and spatial changes in aortic and carotid artery structure in all three vessel layers, along with putative gene expression changes that underlie Na-induced exacerbation and progression of arterial stiffness along the disease course of hypertension and its end-organ complications. Aim 3. Elucidate the role of genetic mechanisms in the causation of arterial stiffness in the context of polygenic salt-sensitive hypertension via genome-wide scan of F2[Dahl S x Dahl R]-intercross male and female rats identifying common and sex-specific quantitative trait loci (QTLs) that contribute to arterial stiffness individually or interactively. Altogether, these three aims will elucidate the relationship of aortic and carotid arterial stiffness to polygenic (essential) hypertension and stroke in a Na-induced stroke-prone hypertension rat model, as well as give insight into causal cellular, molecular, and genetic mechanisms.
PUBLIC HEALTH RELEVANCE: The emerging importance of arterial stiffening in clinical studies demonstrating the association of increased arterial stiffness and cardiovascular diseases like hypertension, stroke, coronary heart disease, and chronic kidney disease, has pinpointed a likely robust predictive parameter of these diseases. Accordingly, our research will help to elucidate the relationship of arterial stiffness to hypertension and give insight into causal mechanisms of abnormal arterial stiffness. This information will help to establish new intervention and prevention strategies for essential hypertension and its associated target organ complications like stroke, coronary heart disease, and chronic kidney disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
-
批准号:8484427
-
项目类别:
-
资助金额:$38.29万
-
财政年份:2010
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
-
批准号:8145199
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2010
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
-
批准号:8292163
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2010
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Functional characterization of ATP1A1 and DEspR variants associated with essentia
-
批准号:7701362
-
项目类别:
-
资助金额:$36.56万
-
财政年份:2009
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Functional characterization of ATP1A1 and DEspR variants associated with essentia
-
批准号:7932877
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2009
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Gender-specific genetic determinants of hypertension and end organ disease
-
批准号:7461206
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2008
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Gender-specific genetic determinants of hypertension and end organ disease
-
批准号:7676110
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2008
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Gender-specific genetic determinants of hypertension and end organ disease
-
批准号:7888204
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2008
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Molecular Genetics of the ET-1/AngII Receptor
-
批准号:6459132
-
项目类别:
-
资助金额:$40.47万
-
财政年份:2002
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Molecular Genetics of the ET-1/AngII Receptor
-
批准号:6622909
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2002
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Molecular Genetics of the ET-1/AngII Receptor
-
批准号:6852637
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2002
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Molecular Genetics of the ET-1/AngII Receptor
-
批准号:6718412
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2002
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
SODIUM TRANSPORTER GENES AND ESSENTIAL HYPERTENSION
-
批准号:2467695
-
项目类别:
-
资助金额:$33.76万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Role of Na+ Transporter Genes in Essential Hypertension
-
批准号:6721144
-
项目类别:
-
资助金额:$32.6万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
SODIUM TRANSPORTER GENES AND ESSENTIAL HYPERTENSION
-
批准号:2857932
-
项目类别:
-
资助金额:$34.77万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
SODIUM TRANSPORTER GENES AND ESSENTIAL HYPERTENSION
-
批准号:6139249
-
项目类别:
-
资助金额:$35.82万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Role of Na+ Transporter Genes in Essential Hypertension
-
批准号:6855076
-
项目类别:
-
资助金额:$32.6万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
Role of Na+ Transporter Genes in Essential Hypertension
-
批准号:6468775
-
项目类别:
-
资助金额:$32.6万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
ANG II AND AVP ISORECEPTORS IN BLOOD PRESSURE
-
批准号:6330161
-
项目类别:
-
资助金额:$31.36万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
ANG II AND AVP ISORECEPTORS IN BLOOD PRESSURE
-
批准号:6125874
-
项目类别:
-
资助金额:$29.66万
-
财政年份:1998
-
负责人:NELSON RUIZ-OPAZO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: